Literature DB >> 2942388

Sodium and hypertension. Still a controversy in 1986.

E A Francischetti, V G de Abreu Fagundes, W Oigman.   

Abstract

Interpopulation studies support the hypothesis of a causal relationship between sodium consumption and arterial hypertension. However, although this association has been contradicted by intrapopulation studies, the correlation between sodium and hypertension appears to be genetically determined, as there are both sodium-sensitive and sodium-resistant individuals. Sodium is essential for the maintenance of extracellular and plasma volume equilibrium. It is controlled metabolically by the interaction of several biological systems such as the renin-angiotensin-aldosterone system, the sympathetic nervous system and the kallikrein-kinin and prostaglandin systems. Thus, sodium has a definite role in the mechanism involved in the pathophysiology of the predominantly volume-dependent forms of arterial hypertension. Recently, different structural substances with natriuretic effects have been identified. Natriuretic hormone is a non-peptide substance which inhibits the Na,K-ATPase in response to extracellular volume increase. This hormone acts on the renal tubular cells reducing sodium reabsorption, and at an arteriolar level elevating peripheral resistance by increasing smooth muscle tension. Mammalian atria contain various precursors of biologically active peptides, with potent natriuretic and diuretic effects. They are released in response to volume loading and atrial stretch. Although some data suggest an important role for these natriuretic substances in fluid volume and blood pressure control, their place in physiology and in abnormal clinical states should be more definitively clarified in the next few years.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942388     DOI: 10.2165/00003495-198600314-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  65 in total

1.  Sodium transport and hypertension. Where are we going?

Authors:  M P Blaustein
Journal:  Hypertension       Date:  1984 Jul-Aug       Impact factor: 10.190

2.  The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

Authors:  T G Flynn; M L de Bold; A J de Bold
Journal:  Biochem Biophys Res Commun       Date:  1983-12-28       Impact factor: 3.575

3.  Sodium-potassium pump in low-renin hypertension.

Authors:  F J Haddy
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

4.  Nutritional factors and blood pressure control: an assessment.

Authors:  C W Callaway
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

5.  Micropuncture studies of the renal effects of atrial natriuretic substance.

Authors:  J P Briggs; B Steipe; G Schubert; J Schnermann
Journal:  Pflugers Arch       Date:  1982-12       Impact factor: 3.657

6.  The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension.

Authors:  T Kawasaki; C S Delea; F C Bartter; H Smith
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

7.  Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.

Authors:  H D Kleinert; T Maack; S A Atlas; A Januszewicz; J E Sealey; J H Laragh
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

8.  Intrarenal localization of the natriuretic effect of cardiac atrial extract.

Authors:  H Sonnenberg; W A Cupples; A J de Bold; A T Veress
Journal:  Can J Physiol Pharmacol       Date:  1982-09       Impact factor: 2.273

9.  Natriuretic activity of human and monkey atria.

Authors:  M N Nemeh; J P Gilmore
Journal:  Circ Res       Date:  1983-09       Impact factor: 17.367

10.  Human essential hypertension: implications of animal studies.

Authors:  L Tobian
Journal:  Ann Intern Med       Date:  1983-05       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.